ALX Oncology Holdings Inc.
ALXO • NASDAQ
ALX Oncology Holdings Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jason W. Lettmann, with a market cap of $268.5M.
CEOJason W. Lettmann
Next Earnings
Upcoming earnings announcement for ALX Oncology Holdings Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.15
Earnings History
Past 12 earnings reports for ALX Oncology Holdings Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | Q4 2025 | -$0.37Est: -$0.34 | -8.8% | - | — |  10-K |
| Nov 7, 2025 | Q3 2025 | -$0.36Est: -$0.37 | +2.7% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.44Est: -$0.37 | -18.9% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.48Est: -$0.34 | -40.3% | - | — | 10-Q |
| Mar 6, 2025 | Q4 2024 | -$0.44Est: -$0.39 | -12.8% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.45Est: -$0.78 | +42.3% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.62Est: -$0.77 | +19.5% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.57Est: -$0.84 | +32.1% | - | — | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$0.79Est: -$0.86 | +8.1% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$1.07Est: -$0.87 | -23.0% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.68Est: -$0.88 | +22.7% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.58Est: -$0.80 | +27.5% | - | — | — |